Alvin Shih's Net Worth
$3.43 Million
Who is Alvin Shih?
Alvin Shih has an estimated net worth of $3.43 Million. This is based on reported shares across multiple companies, which include ZEVRA THERAPEUTICS, INC., and Retrophin, Inc..
SEC CIK
Alvin Shih's CIK is 0001610064
Past Insider Trading and Trends
2024 was Alvin Shih's most active year for acquiring shares with 2 total transactions. Alvin Shih's most active month to acquire stocks was the month of April. 2015 was Alvin Shih's most active year for disposing of shares, totalling 5 transactions. Alvin Shih's most active month to dispose stocks was the month of September. 2015 saw Alvin Shih paying a total of $0.00 for 60,000 shares, this is the most they've acquired in one year. In 2015 Alvin Shih cashed out on 45,416 shares for a total of $1,271,185.79, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZEVRA THERAPEUTICS, INC. (ZVRA) Snapshot price: $7.26
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Retrophin, Inc. (TVTX) Snapshot price: $10.98
EVP Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.24% | -8.75K |
$16.24 | -$142,058.87 | 158.33K |
Scheduled
|
Sep 1
| ||
Form 4
| -4.98% | -8.75K |
$17.75 | -$155,283.62 | 167.08K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| -4.74% | -8.75K |
$14.35 | -$125,568.62 | 175.83K |
Scheduled
|
Mar 1
| ||
Form 4
| -4.53% | -8.75K |
$20.83 | -$182,262.50 | 184.58K |
Scheduled
|
Dec 9
| ||
Form 4
| -4.33% | -8.75K |
$20.12 | -$176,072.88 | 193.33K |
Scheduled
|
Oct 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| -12.14% | -27.92K |
$32.70 | -$912,850.41 | 202.08K |
Scheduled
|
Jun 26
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oaktree Acquisition Corp. III Life Sciences (OACC) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||